Previous studies demonstrated the ability of earlier GHRH antagonists, MZ-4-71 and JV-1-36, to inhibit GH secretion induced by GHRH in somatotroph adenomas [22], an experiment not performed here because of the paucity of tumor samples. Here, GHRH is linked to growth hormone-secreting pituitary adenoma.